Pemphigus vulgaris following a hyperimmune response to typhoid booster

Clinical and Experimental Dermatology

Volumn 21, Issue 6, 1996, Pages 434-436

  Bellaney, G J ^a   Rycroft, R J G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; TYPHOID VACCINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNE RESPONSE; ORAL DRUG ADMINISTRATION; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; VACCINATION;

EID: 0030438578     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00149.x     Document Type: Article

References (5)

1. Hashimoto T, et al. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990; 94: 327-31.
2. Judd KP, Lever WF. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979; 115: 428.
3. Freibelman C et al. Pemphigus vulgaris. Superior sensitivity of monkey esophagus in the determination of pemphigus antibody. Arch Dermatol 1981; 117: 561.
4. Matzner Y, Erlich HA, Brautbar C et al. Identical HLA class 2 alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol (Stockh) 1995; 75: 12-14.
5. Levine MM. Modern vaccines-enteric infections. Lancet 1990; 335:958-61.